Companies / Aktis Oncology, Inc. / Activity
Activity — Aktis Oncology, Inc.
9 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | EcoR1 Capital, LLC Director | Buy | Common Stock | $37.40M | +2.1M +91.50% | 4,348,658 7.87% of shares | high |
| Jan 12, 2026 | Mpm Bioventures 2018, L.P. 10% owner | Buy | Common Stock | $20.03M | +1.1M +12.17% | 10,260,064 18.56% of shares | high |
| Jan 12, 2026 | Gadicke Ansbert 10% owner | Buy | Common Stock | $20.03M | +1.1M +12.17% | 10,260,064 18.56% of shares | high |
| Jan 12, 2026 | Vida Ventures II, LLC 10% owner | Buy | Common Stock | $14.62M | +812K +16.72% | 5,671,825 10.26% of shares | high |
| Jan 12, 2026 | Kim Helen Susan Director | Buy | Common Stock | $14.62M | +812K +16.72% | 5,671,825 10.26% of shares | high |
| Jan 12, 2026 | Foley Todd Director | Buy | Common Stock | $4.19M | +233K +5.82% | 4,235,403 7.66% of shares | high |
| Jan 12, 2026 | EcoR1 Capital, LLC Director | Buy | Common Stock | $2.60M | +144K +71.20% | 347,305 0.63% of shares | high |
| Jan 12, 2026 | Vida Ventures II, LLC 10% owner | Buy | Common Stock | $405.8K | +23K +16.72% | 157,387 0.28% of shares | medium |
| Jan 12, 2026 | Kim Helen Susan Director | Buy | Common Stock | $405.8K | +23K +16.72% | 157,387 0.28% of shares | medium |